RINA BASIN: Open Payments
NPI 1881097152 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 42 payments from 10 companies in 2025. Trend: 2023 $355 · 2024 $760 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $160 |
| Abbott Laboratories | 1 | $149 |
| Alnylam Pharmaceuticals Inc. | 9 | $137 |
| Novo Nordisk Inc | 6 | $123 |
| HEARTFLOW, INC. | 3 | $94 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| Philips North America LLC | 1 | $38 |
| Lilly USA, LLC | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: LEQVIO, CARDIOMEMS, AMVUTTRA, FFRct, Ozempic, Rybelsus, CAMZYOS, MCOT.
Industry payments across NY — which companies pay providers there.
